Clinical trial
A Randomized, Double-Blind, Vehicle-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered Twice-Daily for 6 Months in Adolescents and Adult Subjects With Stable Patchy Alopecia Areata With Optional Long-Term Open-Label Extension
NCT03354637 is registered in ClinicalTrials.gov with Aclaris Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Vehicle-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered Twice-Daily for 6 Months in Adolescents and Adult Subjects With Stable Patchy Alopecia Areata With Optional Long-Term Open-Label Extension
- Lead sponsor
- Aclaris Therapeutics, Inc.
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- November 29, 2017
- Completion date
- September 10, 2019
- Enrollment
- 129 (actual)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.